Noncanonical interactions between serum transferrin and transferrin receptor evaluated with electrospray ionization mass spectrometry.
The primary route of iron acquisition in vertebrates is the transferrin receptor (TfR) mediated endocytotic pathway, which provides cellular entry to the metal transporter serum transferrin (Tf). Despite extensive research efforts, complete understanding of Tf-TfR interaction mechanism is still lacking owing to the complexity of this system. Electrospray ionization mass spectrometry (ESI MS) is used in this study to monitor the protein/receptor interaction and demonstrate the ability of metal-free Tf to associate with TfR at neutral pH. A set of Tf variants is used in a series of competition and displacement experiments to bracket TfR affinity of apo-Tf at neutral pH (0.2-0.6 microM). Consistent with current models of endosomal iron release from Tf, acidification of the protein solution results in a dramatic change of binding preferences, with apo-Tf becoming a preferred receptor binder. Contrary to the current models implying that the apo-Tf/TfR complex dissociates almost immediately upon exposure to the neutral environment at the cell surface, our data indicate that this complex remains intact. Iron-loaded Tf displaces apo-Tf from TfR, making it available for the next cycle of iron binding, transport and delivery to tissues. However, apo-Tf may still interfere with the cellular uptake of engineered Tf molecules whose TfR affinity is affected by various modifications (e.g., conjugation to cytotoxic molecules). This work also highlights the great potential of ESI MS as a tool capable of providing precise details of complex protein-receptor interactions under conditions that closely mimic the environment in which these encounters occur in physiological systems.
Leverence
Rachael
R
Chemistry Department, University of Massachusetts, Amherst, MA 01003, USA.
Mason
Anne B
AB
Kaltashov
Igor A
IA
D006801:Humans; D006863:Hydrogen-Ion Concentration; D007501:Iron / Q000378:metabolism; D011485:Protein Binding; D011990:Receptors, Transferrin / Q000032:analysis* / Q000378:metabolism; D021241:Spectrometry, Mass, Electrospray Ionization / Q000379:methods*; D014168:Transferrin / Q000032:analysis* / Q000378:metabolism
D011990:Receptors, Transferrin; D014168:Transferrin; D007501:Iron
PLoS Biol. 2003 Dec;1(3):E51
14691533
Biochemistry. 2004 Feb 17;43(6):1736-45
14769051
Biochem J. 1984 Apr 15;219(2):505-10
6743230
Biophys J. 2008 Jan 1;94(1):230-40
17872962
Chem Rev. 2007 Aug;107(8):3544-67
17649985
Clin Immunol. 2006 Nov;121(2):159-76
16920030
Methods Mol Biol. 2009;500:221-36
19399427
J Clin Invest. 1963 Mar;42:314-26
13957331
Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3579-83
12642662
J Cell Physiol. 1986 Jul;128(1):1-8
3013902
J Mass Spectrom. 2003 May;38(5):491-501
12794869
Comp Biochem Physiol B Biochem Mol Biol. 2005 Oct;142(2):129-41
16111909
Biochimie. 1986 Mar;68(3):375-81
2874839
Biochemistry. 2003 May 13;42(18):5421-8
12731884
J Mol Biol. 2009 May 22;388(5):954-67
19324057
Structure. 2005 Nov;13(11):1613-23
16271884
Int J Biochem Cell Biol. 2004 Nov;36(11):2137-43
15313461
Hepatology. 1981 Mar-Apr;1(2):114-9
6269977
Cell. 1998 Apr 3;93(1):111-23
9546397
Biochemistry. 2006 May 30;45(21):6663-73
16716077
J Struct Biol. 2005 Dec;152(3):204-10
16343946
Trends Cell Biol. 2007 Feb;17(2):93-100
17194590
Proc Natl Acad Sci U S A. 1983 Apr;80(8):2258-62
6300903
Anal Chem. 2001 Jun 1;73(11):2565-70
11403301
Chembiochem. 2005 Oct;6(10):1788-95
16196027
Trends Analyt Chem. 2008 Oct;27(9):738-748
19802330
Biochem J. 1998 Feb 15;330 ( Pt 1):35-40
9461487
Protein Expr Purif. 2004 Aug;36(2):318-26
15249056
Cell. 2004 Feb 20;116(4):565-76
14980223